English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

tion for Research in Ophthalmology, and Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; and Wilmer Eye Institute, Johns Hopkins University, School of Medicine, Baltimore, Maryland. Correspondence: Dr Tabbara, The Eye Center, 241 Makkah Rd, PO Box 55307, Riyadh 11534, Saudi Arabia (k .tabbara@nesma.net.sa). Financial Disclosure: None reported. Funding/Support: This work was supported in part by a grant from The Eye Foundation for Research in Ophthalmology and The Eye Center, Riyadh, Saudi Arabia. Additional Contributions: Naser Elkum, PhD, Department of Biostatistics and Epidemiology, Dasman Diabetes Institute, Dasman, Kuwait, assisted in the statistical analysis.

Use of Intravitreous Bevacizumab to Treat Macular Edema in West Nile Virus Chorioretinitis